Movement Disorders (revue) - Checkpoint (Ncbi)

Index « Mesh.i » - entrée « Bromocriptine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
British Columbia < Bromocriptine < Bronchi  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 48.
[0-20] [0 - 20][0 - 48][20-40]
Ident.Authors (with country if any)Title
000063 (1999) L E Davis [États-Unis] ; J C AdairParkinsonism from methanol poisoning: benefit from treatment with anti-Parkinson drugs.
000113 (1999) W J Weiner [États-Unis]The initial treatment of Parkinson's disease should begin with levodopa.
000114 (1999) J L Montastruc [France] ; O. Rascol ; J M SenardTreatment of Parkinson's disease should begin with a dopamine agonist.
000190 (2000) C. Ramaker [Pays-Bas] ; W J Van De Beek ; M J Finken ; B J Van HiltenThe efficacy and safety of adjunct bromocriptine therapy for levodopa-induced motor complications: a systematic review.
000272 (2000) R A Hauser [États-Unis] ; W C Koller ; J P Hubble ; T. Malapira ; K. Busenbark ; C W OlanowTime course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
000511 (2001) J L Montastruc [France] ; K. Desboeuf ; M. Lapeyre-Mestre ; J M Senard ; O. Rascol ; C. Brefel-CourbonLong-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease.
000867 (2002) DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
000871 (2002) DA agonists -- ergot derivatives: pergolide: management of Parkinson's disease.
000895 (2002) Robert A. Hauser [États-Unis] ; Nicholas H G. HolfordQuantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's disease.
000B41 (1992) R S Alves [Brésil] ; E R Barbosa ; M. ScaffPostvaccinal parkinsonism.
000B97 (2003) Yoshikuni Mizuno [Japon] ; Nobuo Yanagisawa ; Sadako Kuno ; Mitsutoshi Yamamoto ; Kazuko Hasegawa ; Hideki Origasa ; Hisayuki KowaRandomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease.
000F20 (1992) M. Emre [Suisse] ; U K Rinne ; A. Rascol ; A. Lees ; Yves Agid [France] ; X. LatasteEffects of a selective partial D1 agonist, CY 208-243, in de novo patients with Parkinson disease.
000F67 (2004) Katherine Grosset [Royaume-Uni] ; Fiona Needleman ; Graeme Macphee ; Donald GrossetSwitching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table.
001078 (2004) K Ray Chaudhuri ; Vandena Dhawan ; Sumit Basu ; Gordon Jackson ; Per OdinValvular heart disease and fibrotic reactions may be related to ergot dopamine agonists, but non-ergot agonists may also not be spared.
001083 (2005) Mariese A. Hely [Australie] ; John G L. Morris ; Wayne G J. Reid ; Robert TrafficanteSydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years.
001111 (2005) Peter H. Kraus [Allemagne] ; Peter Klotz ; Arndt Hoffmann ; Johannes Lewe ; Horst PrzuntekAnalysis of the course of Parkinson's disease under dopaminergic therapy: performance of "fast tapping" is not a suitable parameter.
001217 (2005) Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol ; Cristina SampaioEvidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
001464 (1992) J H Friedman [États-Unis]"Rubral" tremor induced by a neuroleptic drug.
001526 (2006) Alexandre Castro-Caldas [Portugal] ; Paul Delwaide ; Wolfgang Jost ; Marcelo Merello ; Adrian Williams ; Paolo Lamberti ; Miguel Aguilar ; Susanna Del Signore ; Pierre CesaroThe Parkinson-Control study: a 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease.
001687 (2006) Ji-Youn Kim [Corée du Sud] ; Eun Joo Chung ; Seung Woo Park ; Won Yong LeeValvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists.
001728 (1991) A S Walters ; W A Hening ; S. ChokrovertyReview and videotape recognition of idiopathic restless legs syndrome.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Bromocriptine" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Bromocriptine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Bromocriptine
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024